Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 LAMEA Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 LAMEA Chlamydia Market by Country
4.2 LAMEA Herpes simplex virus Market by Country
4.3 LAMEA Gonorrhea Market by Country
4.4 LAMEA Syphilis Market by Country
4.5 LAMEA Human papillomavirus (HPV) Market by Country
4.6 LAMEA Other Disease Market by Country
Chapter 5. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 LAMEA Laboratory Testing Market by Country
5.2 LAMEA Point of care (POC) Testing Market by Country
Chapter 6. LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 Brazil Sexually Transmitted Diseases (STD) Testing Market
6.1.1 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Argentina Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 UAE Sexually Transmitted Diseases (STD) Testing Market
6.3.1 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
6.4.1 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 South Africa Sexually Transmitted Diseases (STD) Testing Market
6.5.1 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Nigeria Sexually Transmitted Diseases (STD) Testing Market
6.6.1 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.6.2 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.7.1 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.7.2 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
Unique Offerings 